Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 25, 1999

Primary Completion Date

January 1, 2002

Study Completion Date

November 20, 2003

Conditions
Lymphoma
Interventions
BIOLOGICAL

keyhole limpet hemocyanin

BIOLOGICAL

sargramostim

BIOLOGICAL

tumor cell-based vaccine therapy

Trial Locations (1)

68198-3330

University of Nebraska Medical Center, Omaha

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Genitope Corporation

INDUSTRY

lead

University of Nebraska

OTHER